Kenneth Cunningham, Director at Verona Pharma plc (VRNA), sold 13,104 shares at $0.99 ($13K) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Scheduled sale ($13k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |